309 related articles for article (PubMed ID: 23896378)
1. Metabolomic profiling of oesophago-gastric cancer: a systematic review.
Abbassi-Ghadi N; Kumar S; Huang J; Goldin R; Takats Z; Hanna GB
Eur J Cancer; 2013 Nov; 49(17):3625-37. PubMed ID: 23896378
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of metabolomic profiling of gastric cancer and esophageal cancer.
Huang S; Guo Y; Li Z; Zhang Y; Zhou T; You W; Pan K; Li W
Cancer Biol Med; 2020 Feb; 17(1):181-198. PubMed ID: 32296585
[No Abstract] [Full Text] [Related]
3. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
4. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance-based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis.
Gu J; Huang C; Hu X; Xia J; Shao W; Lin D
Cancer Sci; 2020 Sep; 111(9):3195-3209. PubMed ID: 32369664
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature.
Turkoglu O; Zeb A; Graham S; Szyperski T; Szender JB; Odunsi K; Bahado-Singh R
Metabolomics; 2016 Apr; 12(4):. PubMed ID: 28819352
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
10. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.
Thapar R; Titus MA
Curr Metabolomics; 2014 Apr; 2(1):53-69. PubMed ID: 25632377
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
13. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry.
Hirayama A; Kami K; Sugimoto M; Sugawara M; Toki N; Onozuka H; Kinoshita T; Saito N; Ochiai A; Tomita M; Esumi H; Soga T
Cancer Res; 2009 Jun; 69(11):4918-25. PubMed ID: 19458066
[TBL] [Abstract][Full Text] [Related]
14. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
[TBL] [Abstract][Full Text] [Related]
15.
Ye W; Lin Y; Bezabeh T; Ma C; Liang J; Zhao J; Ouyang T; Tang W; Wu R
NMR Biomed; 2021 Jun; 34(6):e4505. PubMed ID: 33783927
[TBL] [Abstract][Full Text] [Related]
16. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry.
Song H; Peng JS; Dong-Sheng Y; Yang ZL; Liu HL; Zeng YK; Shi XP; Lu BY
Braz J Med Biol Res; 2012 Jan; 45(1):78-85. PubMed ID: 22124703
[TBL] [Abstract][Full Text] [Related]
17. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic studies of human gastric cancer: review.
Jayavelu ND; Bar NS
World J Gastroenterol; 2014 Jul; 20(25):8092-101. PubMed ID: 25009381
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]